0001127602-21-014125.txt : 20210420 0001127602-21-014125.hdr.sgml : 20210420 20210420192022 ACCESSION NUMBER: 0001127602-21-014125 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210416 FILED AS OF DATE: 20210420 DATE AS OF CHANGE: 20210420 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brown Iain Michael CENTRAL INDEX KEY: 0001643456 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 21839123 MAIL ADDRESS: STREET 1: 14 ROYALSTON AVENUE CITY: WINCHESTER STATE: MA ZIP: 01890 FORMER NAME: FORMER CONFORMED NAME: Brown Iain Michael Brown DATE OF NAME CHANGE: 20150527 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-04-16 0001520262 Alkermes plc. ALKS 0001643456 Brown Iain Michael 852 WINTER STREET WALTHAM MA 02451 1 SVP, Chief Financial Officer Ordinary Shares 2021-04-16 4 M 0 208 18.105 A 48570 D Ordinary Shares 2021-04-16 4 S 0 208 19.99 D 48362 D Ordinary Shares 2021-04-19 4 M 0 34792 18.105 A 83154 D Ordinary Shares 2021-04-19 4 S 0 34792 19.9977 D 48362 D Employee Stock Option (Right to Buy) 18.105 2021-04-16 4 M 0 208 0 D 2021-05-20 Ordinary Shares 208 34792 D Employee Stock Option (Right to Buy) 18.105 2021-04-19 4 M 0 34792 0 D 2021-05-20 Ordinary Shares 34792 0 D This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.99 to $20.04. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. These options are fully vested in accordance with their terms. /s/ Shantale Greenson, attorney-in-fact for Iain M. Brown 2021-04-20